Newsletter Subject

Daily Headlines: ADA: Self-Monitoring Blood Glucose No Help for Glycemic Control

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Mon, Jun 12, 2017 11:10 AM

Email Preheader Text

Daily Headlines June 12, 2017 Additional Resources Industry Resources [Official Site for HCPs Learn

Daily Headlines June 12, 2017 [ADA: Self-Monitoring Blood Glucose No Help for Glycemic Control]( [D.C. Week: Price Defends Budget Cuts for His Agency]( [Lifestyle Intervention Benefits Latinas With Prediabetes]( [Candidates Square Off in Debate for AMA Presidency]( [Pounds Shed Before Adulthood Reverses T2D Risk for Heavy Kids]( Additional Resources [Diagnosis and Treatment of Relapsed Myeloma]( [AML: Beware of Pre-leukemic Clones Surviving Chemotherapy]( [Support for Omitting ALND in Early Breast Cancer]( Industry Resources [Site For Endocrinologists Low Testosterone Due To Certain Medical Conditions. Treatment Info]( [Official Site for HCPs Learn About Repatha® (evolocumab) by Visiting the Official Website.]( [NSCLC Professional Site - FDA Approved Treatment Option Drug Option For Your Previously Treated Metastatic NSCLC Patients.]( Recent Headlines [Empathy Key for Communicating with Patients]( [iMedicalApps: 'Virtual Visits' Improve Infectious Disease Care]( ['These Drugs Are Double-Edged Swords': What We Heard This Week]( ['Social Jet Lag' Called Potentially Hazardous]( CME/CE [Better Tattoo Removal Outcomes with Patch]( CME/CE ADVERTISEMENT This Week's Survey [Should All DTC Drug Ads Include Cost Info?]( [At its June meeting, the AMA's House of Delegates will debate whether to ask the federal government to require that]([direct-to-consumer drug ads include pricing information](. CME Spotlights [Can your pharmacist substitute your biologic? Is that OK?]( [Source: France Foundation]( [Playing The Offense In Advanced Basal Cell Carcinoma: A Team Approach To Treatment And Management]( [Source: RMEI Medical Education]( [Breast Cancer @POC w/Watson]( [Source: @Point of Care]( [MDS and Acute Myeloid Leukemia (MDS and AML) @Point of Care]( [Source: @Point of Care]( [Skin Cancers @Point of Care]( [Source: @Point of Care]( [Clinical Context:Gynecological Cancers Case Studies1]( [Source: Projects in Knowledge, Inc.]( [Clinical Context:Gynecological Cancers CaseStudies4]( [Source: Projects In Knowledge, Inc.]( [Clinical Context:Multiple Myeloma CaseStudies1]( [Source: Projects In Knowledge, Inc.]( [Clinical Context:Multiple Myeloma CaseStudies2]( [Source: Projects In Knowledge, Inc.]( [Clinical Context:Prostate Cancer CaseStudies1]( [Source: Projects In Knowledge, Inc.]( [Clinical Context:Prostate Cancer CaseStudies2]( [Source: Projects In Knowledge, Inc.]( [A Patient-Centric, Performance Measures-Based Approach to NSCLC]( [Source: RMEI Medical Education]( [Neurology Mastery in Multiple Sclerosis Case Studies 1]( [Source: Projects In Knowledge, Inc.]( [Outcomes in NSCLC: A Focus on Quality Improvement-Part1]( [Source: RMEI Medical Education]( More of Today's Stories [AMA Leadership Presses Members to Defend ACA]( [ADA: SMBG May Tighten Glycemic Control in Type 2 Diabetes]( CME/CE [AMA President Urges Docs to Speak Up on Healthcare Issues]( [ADA: Sotagliflozin Add-On Boosts Glycemic Control in T1D]( CME/CE [Say What? Dangers of Miscommunicating]( [Severe Childhood Obesity Tied to Higher T2D Rates]( [Why Compensation for Some Medical Specialties is in Decline]( [Women in Poor Countries Prefer At-Home HPV Testing]( CME/CE [PodMed: A Medical News Roundup From Johns Hopkins]( [Cinnamon for Weight Loss: That's Improbable!]( More news from MedPage Today® Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. © 2017 Medpage Today, LLC. All rights reserved. Use of this site constitutes acceptance of the [MedPageToday.com]( [terms of use]( and [privacy policy](. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Medpage Today is located at 345 Hudson Street, New York, NY 10014 [Remove me from this list](lst=Daily%20Headlines) [Manage my e-mail settings](

Marketing emails from medpagetoday.com

View More
Sent On

30/06/2024

Sent On

30/06/2024

Sent On

29/06/2024

Sent On

29/06/2024

Sent On

28/06/2024

Sent On

28/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.